Talphera (TLPH) EPS (Basic) (2010 - 2025)

Talphera (TLPH) posted quarterly EPS (Basic) of $0.0 for Q1 2025, up 100.88% quarter-over-quarter from -$0.32 in Q4 2023.

Talphera (TLPH) EPS (Basic) (2010 - 2025) Analysis & Trends

Talphera's EPS (Basic) history runs 15 years deep, the most recent figure standing at $0.0 for Q1 2025.

In Q1 2025, EPS (Basic) changed N/A year-over-year to $0.0; the TTM figure through Dec 2025 stood at $0.0 (changed N/A YoY), while the FY2025 annual figure was $0.0, changed N/A from the prior year.
EPS (Basic) for Q1 2025 stood at $0.0, up from -$0.32 in the prior quarter.
The five-year high for EPS (Basic) was $8.58 in Q2 2022, with the low at -$1.72 in Q1 2021.
The 4-year median for EPS (Basic) is -$0.56 (2022), against an average of $0.08.
The sharpest annual moves came in 2022 and 2023: EPS (Basic) soared 619.0% in 2022, then tumbled 104.66% in 2023.
Talphera's EPS (Basic) stood at -$1.32 in 2021, then jumped by 46.74% to -$0.7 in 2022, then soared by 55.11% to -$0.32 in 2023, then surged by 100.88% to $0.0 in 2025.
Business Quant data shows TLPH's EPS (Basic) at $0.0 in Q1 2025, -$0.32 in Q4 2023, and -$0.08 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn	-0.49
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn	2.07
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	0.45
5	United Therapeutics	22.19 Bn	19.53 Bn	683.80 Mn	7.82
6	Viatris	18.68 Bn	17.79 Bn	1.46 Bn	-0.10
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	1.43
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	0.11
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Talphera	89.95 Mn	89.95 Mn	-	-0.05

Download Data